datroway.com

.com crawl

First seen 2026-04-21 · Last seen 2026-05-12 · ok HTTP/1.1 200 1242 ms crawled 2026-05-15

NL · 20.50.139.246 · AS8075 Microsoft Corporation

Reputation 95/100 weak security headers

Classifying

HTML metadata

Title
DATROWAY® (datopotamab deruxtecan-dlnk) | Patient Information
Description
DATROWAY® may be right for you depending on your cancer type. Please see full Prescribing Information and Medication Guide.
Language
en
Canonical
https://datroway.com

Open Graph

url
https://datroway.com/
title
DATROWAY® (datopotamab deruxtecan-dlnk) | Patient Information
site name
DATROWAY Patient Information
description
DATROWAY® is an FDA-approved treatment option. Please see full Prescribing Information and Medication Guide.

Technology

Cookie consent
  • OneTrust
Fonts
  • Adobe Fonts
  • Google Fonts

Third-party hosts loaded (5)

  • fonts.googleapis.com×4
  • use.typekit.net×2
  • cdn.cookielaw.org×1
  • fonts.gstatic.com×1
  • p.typekit.net×1

Contact

Phone

Registration

Registrar
MarkMonitor Inc.
Created
2022-03-03
Expires
2031-03-03 1748 days left
Updated
2026-03-03
Name servers
  • ns1.markmonitor.com
  • ns2.markmonitor.com
  • ns3.markmonitor.com
  • ns4.markmonitor.com
  • ns5.markmonitor.com
  • ns6.markmonitor.com
  • ns7.markmonitor.com

DNS records live

NS
  • ns1.markmonitor.com
  • ns2.markmonitor.com
  • ns3.markmonitor.com
  • ns4.markmonitor.com
  • ns5.markmonitor.com
  • ns6.markmonitor.com
  • ns7.markmonitor.com

Email authentication no MX

SPF
not published
DMARC
not published
DKIM
no key found at common selectors

Certificate (current)

DigiCert Global G2 TLS RSA SHA256 2020 CA1
from 2026-01-07 to 2026-12-17
Expires in 211 days

HTTP security headers

Header hygiene 30/100 Checked live page: https://datroway.com/

findings
  • missing HSTS
  • missing Content Security Policy
  • missing frame protection
  • missing content type protection
  • missing Referrer Policy
  • missing Permissions Policy

Links to (2)

Linked from (1)